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QUALITY CRITERIA FOR THE DETECTION OF ANALYTES IN TEST SAt-fPLES ~o~i th 
special reference to anabolic agents and related compounds 
\~ . G . de Ruig ( RIKILT), R. \V . Stephany (RIVH) and G. Dijkstra (RIVM) 
SU.HMARY 
Analytica! results serve a purpose and this can always be defined in 
terros of a decision to be taken. Examples are classifying a material 
according to value, or safety decisions such as ''no action required, 
all is well" , The nature of the decision determines the requirements 
put to the analysis such as the quantitative ones, e . g . limits of 
detection, or the qualitative ones, e.g . amount of certainty, that the 
identification of a compound is unambiguous . The classica! approach to 
unambiguity is a detailed description of procedures. 
However, this approach has some drawbacks. A standard method by virtue 
of its immobility is apt to become old-fashioned. Modern highly 
sophisticated apparatus ask for dedicated analytica! procedures, which 
are not generally applicable. Changes in custom-made reagents or 
equipment force adaptation of the procedure. 
For quantitative analysis the flexibility can be attained by a system 
of quality parameters . These are inadequate for qualitative analysis . 
In order to create a system in which well-defined limits of ambiguity 
can be set we have introduced the concept of "quality criteria" to be 
applied to the identification method(s) used . 
The quality criteria for each detection method have to be stated and 
adopted by a board of experts for that detection method . 
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But, once an analysis fulfils the adopted criteria of a detection 
method, the presence of the investigated analyte in the sample can be 
taken as proved within the limits of ambiguity chosen for the deelsion 
process. 
In particular for spectrometric identification methods such quality 
criteria are of essential interest. 
Quality criteria are presented for low resolution MS, high resolution 
MS, IR, on line spectrometric detection with TLC and HPLC, furthermore 
for off line separation techniques (GC, TLC, HPLC), as \o~ell as general 
considerations for the \'lhole analytica! procedure . 
The criteria are incorporated in the EEC ''Commission Deelsion of 14 
July 1987 laying down the methods to be used for detecting residues of 
substances having a hormonal action and substances having a thyrosta-
tic action" . 
Tbraughout this report , some differences with respect to the EEC 
text occur. 
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1 LIST OF ABBREVIATIONS AND SYNBOLS 
ISO International Organization for Standardization 
BCO BCO Centre for Research, Breda, The Netherlands 
CIVO Central Institute for Food and Nutrition Research TNO, Zeist, 
The Netherlands 
Janssen Pharmaceutica = Janssen Pharanace utica, Beerse, Belgium 
Organon= Organon International B.v., Oss, The Netherlands 
RIKILT = State Institute for Quality Control of Agricultural Products, 
Wageningen, The Ne therlands 
RIVH National Institute for Public Health and Environmental Hygiene, 
Bilthoven, The Netherlands 
RUU University of Utrecht, Utrecht, The Netherlands 
GC gas liquid chromatography 
HPLC high pressure liquid chromatography 
HPTLC high performance thin layer chromatography 
HIU.1S high resolution mass spectroscopy 
IA immunoassay 
IR infrared spectroscopy 
LIU-1S low resolution mass spectroscopy 
HS mass spectroscopy 
RIA radioimmunoassay 
Rf relative retention elistance 
SOP Standard Operating Procedure 
SP spectrometry, e . g . via diode array detection of UV range 
TLC thin layer chromatography 
uv ultra violet 
I off-line hyphenated techniques 
on-line hyphenated techniques 
e .g. HPLC/GC-HS = HPLC off line follm~ed by GC \olith on-line HS. 
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For RIA: 
T total radioactivity (counts per minute, cpm or desintegrations 
per minute, dpm) added to a sample 
8 radioactivity of the bound fraction of a sampl e 
Bo = radioactivity of the bound fraction of a blank sample 
8/8o fraction of the radioactivity of the bound fraction of a 
sample \Üth respect to that of a blank sample ("fraction of 
binding \olith respect to zero binding") 
%B/8o radioactivity of the bound fraction of a sample expressed as a 
percentage of the blank (i.e. 8 x l00/8o) 
8o/T fraction of t he radioactivity of the bound fraction of a blank 
sample \dth respect to the added activity ( "fraction of zero 
binding 1vith respect to total") 
NSB non specific binding = aspec i fic binding (ASB) 
For NS: 
amu atomie mass unit 
Cl chemical ionization 
EI electron impact ionization 
H mass 
Z charge 
HFH heptafluorobutyric acid or heptafluorobutyryl derivative 
MOX methoxime derivative 
TMS trimethylsilyl derivative 
HOX-TNS = methoxime and trimethylsilyl derivative 
F+ fragment ion 
(F+l)+ = natural isotape satellite, l H/Z higher than the corresponding 
main isotape fragment ion 
H+ molecular ion 
(H+l)+ = natural isotape satellite, l H/Z higher than the corresponding 
main isotape molecular ion. 
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2 INTRODUCTION 
This document introduces a nel., approach to quality guarantees for 
analytica! chemical investigations , viz. the application of well 
described quality criteria for interpretation of results instead of 
well described methods of analysis. The new approach holds for 
qualitative analysis, and aims to prevent false positive results. 
In trade traffic, forensic control, and particularly in case of 
dispute, the results of chemical analysis have to be unambiguous a nd 
interpretable in only one way. 
To achieve this certainty , it has become the usual practice to 
describe an analytica! method in great de tail. This is practised in 
Standard Nethods of ISO and numerous international commodity organiza-
tions and national organizations for standardization. 
Methods have to be described in terms of quality parameters such as 
s pecificity, accuracy, precision (repeatability and reproducibility), 
limit of de tection, sensitivity , practicability and applicability. 
To characterize the merits and the quality parameters of such a method, 
extensive investigations and collaborative studies have to be carried 
out. 
The Codex Alimentarius Commission distinguishes four types of methods 
of analysis . 
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a) Defining Methods (Type I) 
Definition: A method which determines a value that can only be 
arrived at in terms of the method per~ and serves for calibration 
purposes. 
Examples: Howard Mould Count, Reichert-Meissl value, loss on drying, 
salt in brine by density. 
b) Keferenee Methods (Type II) 
Definition: A type II method is the one designated Keferenee Method 
where type I methods do not apply . It should be selected from type 
lil methods (as defined below). It should be recommended for use in 
cases of dispute and for calibration purposes . 
Example: Potentiometric method for halides . 
c) Alternative Approval Methods (Type lil) 
Definition: A type lil method is one which roeets the criteria 
required by the Codex Committee on Hethods of Analysis and 
Sampling for methods that may be used for control, inspeetion or 
regulatory purposes. 
Example : Volhard method or Hohr method for chlorides . 
d) Tentative Hethod (Type IV) 
Definition: A type IV method is a method which has been used 
traditionally or else has been recently introduced but for which 
the criteria required for acceptance by the Codex Committee on 
Methods of Analysis and Sampling have not yet been determined. 
Examples : Chlorine by X-ray fluorescence, estimation of synthetic 
colours in foods . 
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It is clear that in the case of type I methods, where the result is 
defined by the method, an exact experimental protocol for the methad 
is mandatory. However, the other types of methad are also usually 
described in great detail. For these methods, however, the approach of 
exact tormulation of the analytica! procedure has some drawbacks, 
~o~hich are \olell recognized . 
1. A standard method, by virtue of its immobility, may hamper new 
developments, and is apt to become old- fashioned. 
2 . Modern analytica! procedures use frequently custom-made reagents 
and equipment, which can vary in chemica! behaviour forcing adaptation 
of the procedure. 
3 . In modern analytica! procedures, highly sophisticated and expensive 
apparatus and procedures are applied , which cannot be described in 
terrus generally applicable in other laboratories. 
A cornplication for qualitative analyses, in particular for residue 
analyses, is that some of the quality parameters as stated above , are 
irrelevant for qualitative results (e.g. repeatability and reproduci-
bility). It is for this reasen that there are so few standard qualita-
tive methods. On the ether hand, there is a need for unambiguous 
results in qualitative analysis as well. 
To break this deadlock, "quality criteria" are introduced in this 
document persuing to prevent false positive results . 
For a positive conclusion ("the analyte is identified in the sample 
examined"), the analytica! results have to fulfil the quality criteria 
laid down for the detection methad applied . 
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Whe n consensus is achieved about the criteria, the conclusion hold s , 
irre8pective of the analytica! proced ure details l eading to the 
analytica! result. 
Analytica! procedures applying highly sophisticated techniques are nat 
easily transferable to another laboratory in exactly the same \'lay, 
making collaborative studies virtually impossible . Nevertheless the 
same quality criteria can be applied to the ultimate identification 
method . 
For the application of adopted quality criteria for identification, 
collaborative studies are superfluous. Of course , collaborative 
studies remain useful to test the quality of a fully described 
analytica! method, or to control the performance of laboratories. 
The quality criteria for each identification methad have to be stated 
and adopted by a board of expert s for that identification method. 
In this document, quality criteria are presented for radioimmunoassay, 
gas chromatography, thin layer chromatography (TLC), high pressure 
liquid chromatography (HPLC), HPLC and TLC \'lith UV spec trum identific-
ation, gas chromatography with mass spectrometric identification and 
infrared spectroscopy, as well as general considerations for the whole 
analytica! procedure . 
The ne\'l approach, introduced in this document, does nat imply that an 
exact experimental protocol ("Standard Operating Procedure" , SOP) for 
a methad of analysis s hould no langer be mandatory. In the framewerk 
of good laboratory practice each laboratory has the responsibility of 
making such protocol for its 0\m methods of analysis, which are used 
in analytica! con trol. The degree of specificity has to be kno\vn, and 
the r esult of the analysis s hould be related to this specificity . When 
the me thad is improved or altered, an adapted new protocol has to be 
made within t he laboratory . SOP's should be available on request. 
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The criteria for mass speetrometry are extrapolated for general 
application from statements accepted by a working group of mass 
spectroscopie experts composed of R. lv . Stephany (RIVH) (chairman), 
J, Freudenthal (RIVM), J.G. Leferink (BCO), H.C. tenNoever de Brauw 
(CIVO), A. Tas (CIVO) and L.G.M. Th . Tuinstra (RIKILT) on 1985-03-19. 
The criteria for infrared spectroscopy were stated by W.G. de Ruig 
(RIKILT) and J.H. Weseman (RIKILT) withadvice from G. Dijkstra (RIVM). 
On 1987-03-19 the infrared criteria have been accepted as a reliable 
method for the detection of analytes in test samples by a group of 
experts on infrared spectroscopy composed of G. Dijkstra, (RIVM) 
(chairman), L.A. van Dijck (Organon), c. Funke (Organon), J . H. van der 
Maas (RUU), W.G. de Ruig (RIKILT), W.A. Seth Paul (Janssen Pharmaceu-
tica) and R.l-/. Stephany (RIVH) . 
The criteria were submitted to the EEC working group "Hethods of 
Analysis for Residues'', consisting of w. Daelman, (EEC) (chairman), D. 
Arnold (FRG), Hrs. B. Boursier (France), N.F. Gunningham (UK), Hrs . G. 
Horetti (Italy), W.G. de Ruig (Netherlands) (rapporteur), R.W. Stephany 
(Netherlands) and H. Verburg (Netherlands), EEC doe VI/4705/86. This 
werking group was in charge of formulating quality criteria for methods 
of analysis as required by EEC Council Directive of 1985-12-20 concer-
ning the introduetion of "Community methods of sampling and analysis 
for the monitoring of foodstuffs intended for human consumption" 
(85/591/EEC) . After some amendments , the criteria reported in this 
report were adopted by the Working Group, and combined with definitions 
a nd criteria collected by n. Arnold (Bundesgesundheitsamt , Berlin), 
EEC doe VI/4700/86. The latte r were dealing lqith specificity, accuracy , 
precision, limit of detection, sensitivity, practicability and 
a pplicability, limit of decision, limit of quantification, calibration 
curves, interterences and reference material. 
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Both docurnents \o~ere brought tagether into a draft Commission Decision, 
EEC doe VI/6290/86. 
On 1987-04- 13, this draft was discussed and adopted \olith minor 
arnendrnents by an ad hoc group of laboratory experts of all EEC memher 
states . 
On 1987-04-23, the Standing Veterinary Gomruittee has unanirnously 
adopted this draft, and eventually on 1987-07-14 the EEC Commission 
authorized it as "Conunission Decision of 14 July 1987 laying down the 
methods to be used for detecting residues of substances having hor-
monal action and of substances having a thyrostatic action" 
(87/410/EEC, EEC Official Journal NoL 223 , 1987-08-11, p . 18-36). 
Herewith the criteria stated in this report are incorporated in the 
above Commission Decision, with force of law in the European 
Community. 
Summarizing: 
Quality criteria are stated for qualitative analysis, to prevent 
false-positive results. 
The criteria are applicable, irrespective of the applied metbod is 
ringtested or not . 
The criteria present a high degree of flexibility as to the metbod 
applied. 
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3 DEFINITIONS REGARDING THE PRESENGE OF AN ANALYTE 
3 . 1 Analyte: a component of a test sample the pt·esence of 1o1hich has to 
be demonstrated. The term "analyte" includes derivatives formed 
from the analyte during the analysis wilerever this is applicable. 
3.2 Standard material: a wel! defined substance in its hig hest 
attainable purity to be used as a reference in the analysis. 
3.3 Positive result: the presence of the analyte in the sample is 
proved, according to the rnethod, when the general criteria, and 
the criteria specified for the relevant detection rnethod, are 
fulfilled . 
3.4 Negative result: if not all of the general criteria, and the 
criteria specified for the relevant methad are fulfilled, the 
analysis , according to the method, is not able to prove the 
presence of the analyte in the sample . 
NOTE 
The result of the analysis does not provide proof for the absence of 
the analyte in the sample . 
R8727. 9 - 10 -
- 10 -
3.5 Limit of decision: the lowest analyte content which, if actually 
present, will he detected with reasonahle statistica! certainly 
and can he identified according to the identification of the 
method. 
3.5 Co-chromatography: the following procedure is applied. 
The purified test solution prior to the chromatographic step is 
divided up into two parts . 
a. One part is chromatographed as such . 
h . The standard material of the analyte that is to he identified 
is added to the other part, and this mixed solution of analyte 
and standard material of analyte is chromatographed . 
The amount of added standard material has to he about equal to 
the estimated or expected amount of the analyte . 
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4 GENERAL CONSIDERATIONS FOR THE \~HOLE ANALYTICAL PROCEDURE 
4.1 2_e~e.E_al_~r!t~r!a_f~r_t.!:!_e_w.!:!_ol_e_p.E_o~e~u~ 
The methad must have been proved to be able to distinguish between 
the analyte and all known intertering materfals in the appropriate 
matrix . 
The physical and chemica! behaviour during the analysis of the 
analyte should be indistinguishable from that of the corresponding 
standard material in the appropriate matrix . 
4 . 2.1 Reference samples containing known amounts of analyte must be 
carried through the entire procedure simultaneously witlt each 
batch of test samples analysed. Alternatively, an internal 
standard may be added to test samples. 
4. 2 . 2 )<{ Appropriate reference samples having a content of standard 
material close to that of the expected analyte content of the 
samples must be subjected to the same derivatiza tion procedure 
as the samples , including any post-derivatization clean-up . 
4.3 ~r.!_t~r.!_o~ ..!_o.E_ .E_h~~ff_-l_i~e_p.!:!_y~i~al_~n~/~r_c.!:!_e~i~al_E_r~c~n~e~­
t.E_a!i~n~E_U.E_i..!_i~a!i~n_a~d_s~p~r~t.!_o~,_i..!_~p.E_l.!_e~ 
The analyte should be in the fraction that is characteristic for 
the corresponding standard material in the a ppropria te matrix 
material. 
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4.4 _g_r.!.t~r.!.o~ .!_o~ ~n.::_l!n~ ~eE.a~a...!:_i~n...!... !f_a.Ep..!_i~ (e.g. GC) 
The analyte should elute at the retentien time which is charac-
teristic for the corresponding standard material in the 
appropriate matrix material . 
4.5 ~r~p~r~t!o~~f_t~e_t~s...!:_ ~a~ple 
The test sample should be prepared from the laboratory sample in 
such a way that there is a maximwn chance of detecting the analyte, 
if any present . 
4.6 ~r~p~r~t!o~ ~f_t~e_t~s...!:_ J.?.O~t!o~ 
The test portion is prepared from the test sample in such a way 
that there is a maximum chance of detecting t he analyte, if any 
present. 
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5 QUALITY REQUIREHENTS FOR DETERNINATION OF AN ANALYTE BY RIA 
For screening purposes 
5. 1 The working range of the calibration curve has to be specified a nd 
has in general to cover a concentration range of at least one 
decade . 
5 . 2 Control samples have to be included in each assay . Concentration 
l evels: zero and a t lower, middle and upper parts of the working 
range. Results for these have to be in l i ne with those of previous 
assays . 
5 . 3 At the limit of decision, the within-run coefficient of variation 
for the control samples has to be l ess than 0,15. 
5.4 A minimum of 6 cal ib ration points is required, adequately 
distributed a long the calibration curve . 
5.5 The r ecovery must be controlled and specif i ed . 
5 . 6 If l ogit-log transformation of the original data is applied , the 
within-run coefficient of correlation of t he calibration curve has 
to be at least 0,985. 
5.7 The calibration must have its highest precision around the limit 
of decision. 
5 . 8 Adequate quality control parameters ha ve t o be i n line with those 
of preceding assays , e . g . Bo/T, NSB, s lope and in t ercept of the 
cal ibration curve . 
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NOTE Compliance witlt these quality requirements does not exclude the 
possibility of false positieve results orginating from sys tematic 
errors s uch as antibody cross reactivities and interterenee 
f rom non-representative sample material. 
Reference: Nederlandse Staatscourant 250, December 23, 1983 
Benelux document SP/LAB/h (84) 17 (1984) 
EEC document VI/244 7/84-EN 
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6 CRITERIA FOR IDENTIFICATION OF AN ANALYTE llY GC 
6.1 The analyte should elute at the retentien time which is charac-
teristic for the corresponding standard material. 
6.2 The nearest peak maximum in the chromatagram should be separated 
from the designated analyte peak by at least one full width at 
half maximum height. 
6.3 For identification, additional co-chromatography in the GC stage 
is mandatory. 
As a result, the peak presumed to be due to the analyte s hould be 
intensified only and the width at half maximum height should 
be within + 10% of the original width . This requirement may be 
taken as fulfilled whenever the retentien times are identical 
within 10% of the peak width at half maximum height . 
Reference: RIVH report 368301 007 (1986) 
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7 CRITERIA FOR IDENTIFICATION FOR AN ANALYTE BY TLC OR HPTLC 
7.1 The Rf value(s) of the analyte should agree with the Rf value(s) 
c haracteristic for the standard material . This requirement is 
fulfilled whenever the Rf value( s) of the analyte is (are) l~i thin 
3% of the Rf value(s) of the standard material under the same con-
ditions . 
7.2 The visual appearance of the analyte should be indistinguishable 
form that of the standard material. 
7 . 3 The centre of the nearest spot to that due to the analyte s hould 
be separated from it by at least half the s um of the spot diame-
ters . 
7 . 4 For identification, additional co-chromatography in the TLC step 
is mandatory . As a result the spot presumed to be due to the ana-
lyte should be intensified only; a new spot s hould not appear, and 
the visual appearance should not change. 
7.5 For confirmation, two dimensional TLC is mandatory. 
Reference: EEC document 690/VI/73, rev. version (1974) 
Benelux document SP/LAB/h( 74) 5 (1974) 
Benelux document SP/LAB/h(76) 5 (1976) 
RIVM Report 367910 004 (1983) 
RIKILT SOPs A 441 , A 443, A 444 (1986) 
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8 CRITERIA FOR IDENTIFICATION OF AN ANALYTE BY HPLC-SP 
8 . 1 The maximum absorption wave length in the spectrum of the analyte 
should he the same as that of the standard material within a 
margin de termined by the r esolution of the detection system. 
For diode array detection this is typically within + 2 nm. 
8.2 The spectrum of the analyte should not he visually different from 
the spectrum of the standard material for those part s of the two 
spectra with a relative absorbsnee > 10% . This criterion is met 
when the same maxima are present and at no observed point is the 
difference between the two s pectra more than 10% of the absorbsnee 
of the standard materia l . 
8.3 For identification , co- chromatography in the HPLC step is mandatory . 
As a result, the peak presumed to he due to the analyte should he 
intensified only . 
Reference: RIVM report 368301 005 (1985 ) 
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9 CRITERIA FOR IDENTIFICATION OF AN ANALYTE BY TLC-SP OR HPTLC-SP 
9.1 The Rf value(s) of the analyte should agree with the Rf value(s) 
characteristic for the standard material. This requirement is 
fulfilled when the Rf value(s) of the analyte is (are) within 
± 3% of the Rf value(s) of the standard material under the same 
conditions. 
9.2 The visual appearance of the analyte should be indistinguishable 
from that of the standard material. 
9.3 The centre of the spot nearest to that due to the analyte should 
be separated from it by at least half the s um of the spot diame-
ters. 
9.4 For identification, additional co- chromatography in the TLC-step 
is mandatory. As a result the s pot presumed to be due to the ana-
lyte should be intensified only; a new spot s hould not ap pea r. 
9.5 The maximum absorption wave l ength in the spectrum of the analyte 
should be the same as that of the standard material, within a 
margin determined by the resolution of the detection s ystem. 
9 . 6 The s pect rum of the analyte should not be visually different f rom 
the spectrum of the standard mate ria l . 
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10 CRITERIA FOR IDENTIFICATION OF AN ANALYTE BY GC-H~1S 
10.1 To be classified as high resolution measurements the results 
should be obtained at a resolution of better than 9500 with a 
valley between adjacent peaks of no more than 10% of the peak 
heights . 
10.2 The intensity ratio of the response of the analyte ions F+ and 
(F+l)+ or H+ and (H+1)+ should be equal to the theoretica! value, 
within a margin of A %. 
10.3 The fragment mass of the analyte (as determined by peak matching) 
should be equal to the theoretica! value within a margin of 
B amu. 
NOTE For a number of anabolic agents, values for A and B are listed i n 
Table 1 of the Annex as examples. However, the metbod is oot 
restricted to ana bolic agents, but is genera lly applicable. 
References: 
Nederlandse Staatscourant 250, December 23, 1983 
SP/LAB/h(84) 15 (1984) 
Benelux document 
RIVM Report U 3603/82 Endo(1982) 
RIVH Report U 3408/83 Endo(1983) 
RIVN Report U 206/84 Endo(1984) 
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11 CRITERIA FOR IDENTIFICATION OF AN ANALYTE BY GC-LRNS 
11. 1 Q_a~ ~h.E_o~a_!o~r~phi~ ~r2:_ t;:_r2:_o~ 
11.1 .1 The retentien time of the analyte on GC must be the same as that 
of the standard material, within a margin of+ 5 seconds. 
11.1.2 If an internal standard is used, then the relative retentien 
time (B/A) of the analyte should be equal to that of the stan-
dard material within a margin of + 5/A in the appropriate 
matrix, where: 
A the absolute retentien time of an internal standard, 
in seconds 
B the absolute retentien time of the analyte, in seconds 
11.2.1 All ions monitored must be de rived from analyte eluted at a 
single retentien time. 
11.2 . 2 The intenstties of at least 4 (EI mode ), or at least 2 a nd 
preferabie more (Cl mode), structure relevant ions must be 
determined . 
11 . 2.3 The relative intenstties of the ions detected, expressed as a 
percentage of the intensity of the ion of highest intensity 
(base peak) must be the same as these for the appropriate 
standard material, within a margin of + 20 % (Cl mode) or -:!: 10% 
(EI mode). 
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11.2.4 Mass spectroruetric conditions should be optimized to obtain the 
molecular ion of the analyte i n the HID s pectrum , if possible 
at all. 
NOTE In Tables 2-6 of the Appendix, details of t he molecular and 
fragment ions of the THS , HOX-THS, HOX a nd HFB derivatives of a 
number of anabolic agents and related compound s are presented as 
examples . Ho\-lever, the c rite ria are not restricted to anabolic 
agents but are generally applicable. 
11 . 2.5 Special criteria for dienoestrol, diethylstilboestrol and 
hexoest rol, after EI mode . 
11 . 2 . 4 . 1 As the lltS de rivat i ves of dienoes trol , diethylstilboestrol 
and hexoest rol produce only 3 fragme nt ions i n the EI mode, 
the presence of these stilbenes can only be indicated . 
11.2 . 4.2 The presence of die noestrol a nd diethylstilboestrol i s 
confirmed by analysing the HFB derivative , f ulfilling the 
r equirement in 11.2 . 2 . 
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11.2 . 4.3 The presence of hexoestrol is indicated by the presence of 
the fragment ions (EI mode) 331, 332, 303 and 304 on analy-
sing the HFU derivative. 
For confirmation of the presence of hexoestrol, another 
aliquot is analysed under chemica! ionisation conditions, in 
NH3 gas, positive ions only . 
The intensity ratio of the abundances of the analyte fragment 
ions of cluster 680 and 681 should be equal to that of the 
fragment ions of the standard material, within a margin of 
+ 10%. 
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12 CRITERIA FOR IDENTIFICATION OF AN ANALYTE BY IR SPECTROHETRY 
12.1 Q_e.!_iE_i_!_i~n_o.!_ ~d~q~a.!:_e_p~aks 
Adequate peaks are absorption maxima in the IR spectrum of 
a standard material, fulfilling the following requirements. 
12 .1.1 The absorption maximum is in the \olavenumber range 1800-500 crc1. 
12.1.2 The intensity of the absorption is not less than: 
12 . 1 . 2 . 1 a specific molar absorbance coefficient of: 
- 40 with respect to zero absorbance and 
- 20 with respect to the peak base line 
or 
12.1 . 2.2 a relative absorbance of: 
- 12,5% of the absorbance of the most intense peak in the 
region 1800-500 cm-1 when both are measured with respect to 
zero absorbance and 
5% of the absorbance of the most intense peak in the region 
1800-500 cm-1 when both are measured with respect to their 
peak base line . 
NOTE Although adequate peaks according to 12.1.2.1 may be preterred 
from a theoretica! point of view, those according to 12.1 . 2.2 are 
easier to determine in practice . 
12.2 ~~b~t:_o.!_~d~q~a.!:_e_p~aks 
A minimum of 6 adequate peaks is required. 
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The exact positions of the adequate peaks, in whole \'lavenwnbers, 
act as objective, digitalized parameters for judging spectra of 
samples . 
NOTE The Adequate Peaks in the IR spec tra of 49 anabolic agents and 
related compounds are presented in Table 7 of the Appendix. 
HO\'lever, the methad is not restricted to anabolic agents, but is 
generally applicable. 
12.4.1 The positions of the peaks in the IR spectrum of the analyte 
are compared with the positions of the adequate peaks in the IR 
spectrum of the standard materiaL 
12 . 4.2 The number of peaks in the IR spectrum of the analyte \vhose 
frequencies correspond '"i th an adequate peak in the IR spectrum 
of the standard material within a margin of + 1 cm-1 is deter-
mined. 
12.4.3 The "score" of the standard material in the analyte spectrum is 
calculated . 
1 2. 4 .4 Definition of " score" 
The "score" is t he pe rcentage of the adequate peaks of the 
standard material found in the IR spectrum of the analyte . 
12.5 Criteria 
12 . 5. 1 The score shall be least 50% . 
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12 . 5 . 2 Where no match is found in the sample spectrum for an adequate 
peak of the standard material, the sample s pectrum shall not 
exclude the absorption corresponding with the adequate peak 
(see figure 1). 
12. 5 . 3 The procedure is only applicable to absorption peaks in the 
s ample spect rum with an intensity of at l eas t 3 times the peak 
to peak noise . 
Figure 1 Illustration of criterion 12 . 5 . 2 
standard 
material 
sample A 
sample B 
adequate peaks 
1, 2 and 3 
found: adequa te 
peaks 1 and 3 
found: adequa t e 
peaks 1 and 3 
The spectrum of sample A does not exclude the presence of adequate 
peak 2 ~ criterion 12 . 5.2 fulfilled. 
The s pectrum of sample B excludes the presence of adequate peak 2 
----> criterion 12.5 . 2 is not fulfilled. 
References: 
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Table 1 : Data for confirmation of anabolics by HRNS 
Ion ma ss Intensity ratio 
Derivative** FT ion (F+1)-r ion 
or or 
I>rt ion (N+l)+ ion 
N/Z H/Z 
value nominal t heoretica! 
value value 
amu amu 
DES-UtS z,rt 412 413 0,3777 
DE-UIS z,t+ 410 411 0,3772 
HEX- TNS F+ 207 208 0 , 1889 
NT-TNS z,rt 346 347 not applied 
NT-TMS F+ 256 257 not applied 
NT-HOX-THS N+ 375 376 not applied 
epi NT-HOX-TMS ~ 375 376 not applied 
E2 - di- THS z,t+ 416 417 not applied 
* Calculated on the basis of 12c isotope 12 , 0000 
** DES 
DE 
HEX 
NT 
epi NT 
E2 
R8727.27 
die thyl stilboestrol 
dienoestrol 
hexoes t rol 
19-nortestosterone-17-B 
19- nortestosterone- 17- a 
oestradiol- 17-B 
(nandrolone) 
A 
margin 
% 
8 
8,5 
17 
APPENDIX 
Ion mass 
B 
H/Z N/Z 
theoretica! 
value* 
amu amu 
412 , 2254 0 , 0012 
410,2097 0,0012 
207,1205 0,0007 
346,2328 0,0015 
256, 1827 0,0015 
375,2593 0,0015 
375 , 2593 0,0015 
416,2567 0 , 0015 
- 28 -
- 28 -
Table 2 : THS derivatives of a nuruber of anabolics and related com-
pounds. Ions to be used for confirmation by LR1·1S (EI mode) 
Dienoestrol 
Diethylstilboestrol 
5a-Oestraan (3~,17a)diol 
17a-Oestradiol 
17(3-0estradiol 
17(3-0estradiol-16,16,17(d3) 
Ethinyloestradiol 
Hexoestrol 
Hethandrostenolone 
Hethyltestosterone 
a-Nortestosterone 
(3-Nortestosterone 
Testosterone 
17-a-Trenbolone 
17-(3-Trenbolone 
a-Zearalanol 
(3-Zearalanol 
Zearalanone 
Zearalenone 
* Underlined ion: base peak 
** Internal standard 
H\v 
410 
412 
422 
416 
416 
419 
440 
414 
372 
374 
346 
346 
360 
342 
342 
538 
538 
464 
462 
N/Z* 
410 395 381 
412 397 383 
407 332 242 201 
416 401 326 285 
416 401 326 285 
419 404 329 285 
440 425 300 285 
207 191 179 
372 357 302 282 
359 317 304 284 
346 331 256 215 
346 331 256 215 
360 345 270 226 
342 252 237 211 
342 252 237 211 
538 523 433 307 
538 523 433 307 
464 ll49 335 307 
462 429 333 305 
- -
Table 3 : HOX-TNS derivatives of a number of anabolics and related 
compounds . Ions to be used for conf irmation by L~IS 
(EI mode) 
HIV N/Z* 
Nedroxyprogesteron 474 474 459 443 353 
Hethandrostenolone 401 401 386 370 280 
Nethyltestosterone 403 403 313 298 282 
a-Nortes tosterone 375 375 360 344 285 
(3-Nortestosterone 375 375 360 344 285 
Testosterone 389 389 374 358 268 
a- Trenbolone 371 371 281 266 253 
(3-Trenbolone 371 371 281 266 253 
Zearalanone 493 493 478 462 406 
Ze ar alenone 491 491 460 444 333 
--
* Unde rlined ion: base peak 
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Table 4: NOX derivatives of a number of a na bolics and related 
compounds. Ions to be used fo r confirmation by LRMS 
(EI mode) 
N\ol N/Z* 
Medroxyprogesterone acetate 4 15 415 330 312 287 
Negestrol acetate 4 13 1 .. 13 353 338 310 
Helengestrol acetate 425 425 365 350 322 
--Trenbolone acetate 341 341 298 281 266 
--
* Underlined ion: base peak 
Table 5: HFB-derivatives of a number of a nabolics and related 
compounds. Ions to be used for confirmation by LRNS 
( EI mode) 
EI-mode 
Diethylstilboestrol 
Dienoestrol (DE) 
Hexoestrol (HEX) 
17~-0estradiol, 16, 16,17 ( d3 ) ** 
Cl-mode (NH4 gas) 
Hexoestrol 
* Underlined ion : base peak 
** Internal standard 
R8727 . 29 
Hl~ 
660 
658 
662 
667 
662 
N/Z* 
660 631 447 341 
658 629 445 341 
332 33 1 304 303 
667 454 412 359 
--
681 680 
--
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Table 6: HFB derivatives of stilbenes . Ions to be used for confirmatien 
by LRNS (Cl mode). 
a) Ammonia Cl 
NW N/Z* 
Hexoestrol 662 681 680 484 466 
Diethylstilboestrol 660 678 482 464 
- -
b) Nethane Cl 
l·n-l N/Z* 
Diethylstilboestrol 660 661 465 464 
--
Dienoestrol 658 659 463 462 369 
--
* Underlined: base peak 
Notes 
1) Relative intensities of some of the above ions are too low (around 
10 per cent) to be used reliably for confirmation. 
2) Relative intensities of the ions may vary with amount of analyte 
injected onto the column. In the case of diethylstilboestrol at low 
concentrations under methane Cl, the 661 ion becomes the base peak 
(i.e. there is less fragmentation to the mono-HFB form). It is 
therefore important to compare the relative ion intensities for the 
analyte with those for a standard material at about the same 
concentration. 
3) looization with methane results in cleavage of the hexoestrol 
molecule. The fragment ions of lower mass are not well separated 
from co-ext ractives . 
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Tab1e 7: Adequate Peaks in the infrared 
r e lated products (cm- 1) , 
spectra of 49 anabolics and 
1 2 3 4 5 6 7 8 9 10 
(3 E2 a E2 E2Ac E2diAc E2P E2diP E2S E2Bz E2HE EE 
1701 1766 1712 1763 1729 
1734 1757 
1733 
1610 1610 1620 1696 1600 1610 1615 
1619 
1586 1586 1584 1583 1577 1584 
1500 1502 1501 
1498 1443 1498 1494 1499 1492 1494 1498 1469 1473 
1449 1460 1460 1460 1420 1451 1444 1449 
1416 1444 1419 1433 
1382 1379 1373 1375 1350 1381 1392 1380 1374 1384 
1357 1352 1351 1351 1307 1315 1334 1358 
1320 1313 
1302 
1283 1284 1292 1262 1288 1273 1241 1266 1291 1299 
1250 1253 1276 1248 1249 1247 1223 1278 1257 
1231 1234 1248 1225 1224 1216 1252 1203 
1235 1212 1236 
1156 1154 1152 1198 1151 1197 1176 1176 1183 1184 
1130 1177 1154 1152 1153 1160 
1118 1119 1149 1139 1128 1130 1147 
1102 1101 1120 1135 
1122 
1111 
1056 1074 1017 1040 1086 1078 1097 1067 1055 1069 
1021 1054 1015 1072 1055 1075 1025 1042 1055 
1012 1036 1012 1033 1049 1012 1025 1043 
1013 1014 1018 1022 
1006 
962 994 946 962 917 932 971 
930 970 908 930 
917 945 914 
905 919 
874 866 873 885 878 897 887 889 898 880 
820 821 871 807 866 870 857 
816 847 818 823 
822 
808 
786 787 770 705 785 789 
733 
624 650 688 646 
622 
573 579 568 
519 
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Table 7 Continued- l 
11 12 13 14 15 16 17 18 19 20 
N El E3 Eq Eqln ~T aT TAc TP TiC 
1719 1719 1717 1741 1729 1733 
1612 1621 1610 1623 1622 1666 1654 1672 1669 1667 
1658 1610 1618 1611 1617 
1612 
1580 1584 1501 1588 1599 
1506 1509 
1500 
1467 1499 1452 1470 1480 1470 1432 1449 1450 1470 
1449 1407 1460 1432 1433 li..SO 
1423 
1377 1396 1384 1354 1389 1378 1380 1377 1331 1378 
1352 1361 1353 1360 1362 1331 
1325 1322 1333 
1291 1287 1285 1278 1225 1277 1276 1274 1270 1294 
1255 1250 1254 1246 1208 1233 1231 1232 1240 1272 
1242 1238 1230 
1201 
1183 1174 1158 1169 1199 1189 1185 1182 
1165 1149 1148 1131 1125 
1146 1118 1114 1103 
1133 1103 
1121 
1109 
1062 1055 1068 1056 1066 1067 1041 1080 1043 
1036 1062 1056 1022 1043 1009 
1019 1034 1017 1020 
967 920 964 957 945 941 
905 943 943 
928 
917 
862 877 886 875 849 870 863 863 864 
844 819 871 810 817 
833 851 
823 818 
789 788 787 
702 
658 673 662 
620 
582 
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Ta ble 7 Continued-2 
21 22 23 24 25 26 27 28 29 30 
TD TUn TPP TBz HT HT 9 (11) 13NT etNT NTP NTD 
1734 1738 1734 1709 1741 1734 
1670 1674 1672 1673 1664 1651 1666 1663 1650 1676 
1618 1610 1615 1617 1611 1607 1619 1643 1620 1619 
1615 
1471 1473 1455 lll52 1450 1412 1448 1465 
1415 1424 1435 1422 1453 
1379 1379 1381 1316 1374 1370 1335 1346 1381 
1352 1335 1348 1332 
1327 1315 1332 
1291 1276 1298 1275 1297 1274 1259 1258 1265 1258 
1256 1249 1270 1229 1278 1232 1228 1211 1202 1212 
1216 1208 1229 1234 1206 
1180 1172 1171 1178 1190 1188 1133 1135 1177 
ll10 1156 1173 
1153 
1128 
1104 
1068 1070 1091 1075 1051 1085 
1009 1023 1052 1052 
1023 1025 
944 998 950 956 967 968 968 
941 937 
867 887 862 866 873 882 885 880 884 
748 719 
709 
699 688 692 
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Table 7 Continued-3 
31 32 33 34 35 36 37 38 39 40 
NTL NTPP Et i ~TB a TB TBA p HP HPA HGA 
1735 1730 1737 1732 1731 
1717 1710 
1676 1675 1659 1639 1643 1660 1699 1696 1673 1664 
1619 1618 1612 1663 1664 1608 1629 
1616 1603 
1501 1569 1578 1573 1584 
1473 1447 1430 lll38 1450 1439 1439 1448 1460 
1418 1418 1435 1447 
1381 1330 1383 1379 1391 1375 1386 1349 1365 1390 
1335 1331 1369 1358 1366 
1346 1346 1328 
1322 1321 
1310 
1299 1297 1288 1288 1279 1245 1279 1271 1261 1269 
1269 1259 1232 1267 1240 1237 1233 1253 1260 
1240 1205 1226 1229 1228 1247 
1205 1204 1224 
1176 1177 1191 1199 1198 1162 1186 1187 1167 
1125 1101 1150 1123 1143 
1126 1127 
1109 
1053 1080 1068 1075 1088 1096 948 1093 1080 1083 
1049 1060 1054 1028 1053 1056 1059 
1017 1011 1023 1014 
965 937 987 965 963 
879 869 852 871 871 878 
752 724 795 
704 762 
697 
597 
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Table 7 Continued-4 
41 42 43 44 45 46 47 48 49 
NLGA DE DES HEX DEdiAc DESdiP z Cort HCort 
1738 1757 1763 1714 
1716 1754 
1666 1619 1609 1613 1644 1694 1644 
1625 1608 1615 1648 1610 
1618 
1579 1591 1590 1598 1503 1504 1587 
1513 1514 1516 
1444 1426 1462 1458 1459 1464 1447 1432 
1416 1427 1440 1413 
1389 1333 1337 1368 1363 1381 1391 
1372 1353 
1318 1311 
1260 1247 1282 1218 1218 1210 1259 1269 1271 
1245 1205 1247 1200 1237 
1231 1204 
1205 
1123 1171 1173 1174 1196 1157 1167 1186 1133 
1102 1114 1107 1164 1159 1115 
1037 1012 1019 1076 1096 1075 1047 
1019 1075 1064 1006 
1037 
972 910 989 942 
953 900 
930 
881 853 851 847 865 895 840 875 865 
834 831 830 
826 805 804 
775 721 716 
627 649 646 646 679 
612 620 
551 520 586 573 
510 
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Tab1e 7 Continued-5 
List of abbreviations 
1 (3E2 
2 aE2 
3 E2Ac 
4 E2diAc 
5 E2P 
6 
7 
8 
9 
E2diP 
E2S 
E2Bz 
E2HE 
10 EE 
llH 
12 El 
13 E3 
14 Eq 
15 Eq1n 
16 (3T 
17 aT 
18 TAc 
19 TP 
20 TiC 
21 TD 
22 TUn 
23 TPP 
24 TBz 
25 HT 
26 HT-9(11) 
27 (3NT 
28 aNT 
29 NTP 
30 NTD 
31 NTL 
32 NTPP 
33 Eti 
34 (3TB 
35 aTB 
36 TBA 
37 p 
38 HP 
39 NPA 
40 NGA 
41 NLGA 
42 DE 
43 DES 
44 HEX 
45 DEdiAc 
46 DESdiP 
47 z 
48 Cort 
49 HCort 
R8727.36 
Oestradiol-17(3 
Oestradiol-l7a 
Oestradiol-17-acetate 
Oestradiol diacetate 
Oestradio1-17-propionate 
Oestradiol dipropionate 
Oestradiol-3-sulphate 
Oestradiol-3-benzoate 
Oestradiol-3-methy1ether 
Ethinyloestradiol 
Nestranol 
Oestrone 
Oestriol 
Equilin 
Equilenin 
Testosterone-17(3 
Testosterone-l7a 
Testosterone acetate 
Testosterone propionate 
Testosterone isocaproste 
Testosterone decanoate 
Testosterone undecanoate 
Testosterone phenylpropionate 
Testosterone benzoate 
Hethyltestosterone-17a 
Hethyltestosterone-~9(11) 
Nortestosterone- 17(3 
Nortestosterone-17a 
Nortestosterone propionate 
Nortestosterone decanoate 
Nortestosterone laurate 
Nortestosterone phenylpropionate 
Ethisterone 
Trenbolone-17(3 
Trenbolone- l7a 
Trenbolone acetate 
Progesterone 
Nedroxyprogesterone 
Medroxyprogesterone acetate 
Negestrol acetate 
Melengestrol acetate 
Dienoestrol 
Diethylstilboestrol 
Hexoestrol 
Dienoestrol diacetate 
Diethylstilboestrol dipropionate 
Zeranol 
Corticosterone 
Hydrocortisone 
dR/YL 
